The collaboration will further both companies’ shared mission of transforming clinical trials by expanding access to patient data analytics services. Members of the BlueCloud Sponsor Network will be able to view the locations and numbers […]
From April next year, immediate antiretroviral treatment for HIV in adults and adolescents, a new specialised service for adults with the genetic disorder primary ciliary dyskinesia, and a new specialised service for the serious skin […]
The drug giant is seeking permission to expand the drug’s uses to include first-line treatment of metastatic non-small-cell lung cancer (NSCLC) in patients whose tumours express EGFR mutations. The submission rides on data from the […]
Ozempic is an analogue of human glucagon-like peptide-1 and was reviewed based on the results of eight Phase IIIa clinical trials in the SUSTAIN programme. The drug is recommended to be taken once-weekly as a […]
The partnership represents an expansion of CRT’s translational model that now covers six industry partnerships. It is centred on messenger ribonucleic acid (mRNA) translation, which is said to have the potential to produce treatments that […]